During the past decade, Jewish Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Jewish Hospital" are "Arteriosclerosis" (1 trials), "Atherosclerosis" (1 trials), "Femoral Artery Occlusion" (1 trials), "Femoral Artery Stenosis" (1 trials) and "Peripheral Artery Disease" (1 trials). Many other conditions were trialed in "Jewish Hospital" in a lesser frequency.

Most popular intervention types in "Jewish Hospital" are "Device" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lutonix Catheter" (1 trials), "Lutonix Drug Coated Balloon" (1 trials), "Moxy Drug Coated Balloon" (1 trials), "Standard Uncoated Angioplasty Balloon" (1 trials) and "Standard uncoated Balloon Angioplasty Catheter" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jewish Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Jewish Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Jewish Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jewish Hospital, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".